No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / pharmacokinetics
-
Antipsychotic Agents / therapeutic use
-
Body Mass Index
-
Body Weight / drug effects
-
Child
-
Consensus Development Conferences as Topic
-
Diabetes Mellitus, Type 2 / chemically induced*
-
Diabetes Mellitus, Type 2 / epidemiology
-
Diabetes Mellitus, Type 2 / metabolism
-
Drug Labeling / standards
-
Education, Medical, Continuing
-
Health Surveys
-
Humans
-
Hyperlipidemias / chemically induced*
-
Hyperlipidemias / epidemiology
-
Hyperlipidemias / metabolism
-
Obesity / chemically induced*
-
Obesity / epidemiology
-
Obesity / metabolism
-
Practice Guidelines as Topic
-
Prevalence
-
Psychotic Disorders / drug therapy
-
Psychotic Disorders / metabolism
-
Schizophrenia / drug therapy
-
Schizophrenia / metabolism
-
United States / epidemiology
-
United States Food and Drug Administration